Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain: A Randomized Controlled Trial


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02920528

Organisation Name: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Overal Status: Completed

Start Date: May 1, 2017

Last Update: April 15, 2021

Lead Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Brief Summary: This is a prospective, randomized controlled trial which will be conducted to determine whether sub-dissociative dose ketamine (SDDK) can improve pain control in subjects with chronic pain syndrome presenting to the emergency department with exacerbation of their chronic pain. The investigators also aim to determine whether use of SDDK can reduce the amount of subsequent opioid pain medications required for adequate pain relief in this population.

Conditions:
  • Chronic Pain


Total execution time in seconds: 0.27793002128601